Vitamins for COVID-19: living meta-analysis of clinical studies

Study explorer (study characteristics and results) method abbreviations pdf xlsx

display ongoing studies
Study	Ref.	Design	studied treatment	control treatment	patients	study risk of bias	sample sizes	Results
COVID-19 mild to moderate meta-analysis
Espitia-Hernandez		NRa	Vitamin D	standard of care	COVID 19 outpatients, COVID-19 mild to moderate	NA	28/7	uncontrolled	[uncontrolled] negative PCR on day 10: 100.0% (28/28)
COVID 19 outpatients meta-analysis
Thomas (vitamin c only) NCT04342728		RCT	vitamin C	standard of care	COVID 19 outpatients	some concern	48/50	inconclusive

PE: primary endpoint; (a): to be demonstrated a result must be statistically significant on a primary endpoint (with multiplicity adjustment if necessary);
Study risk of bias assessed for the study primary endpoint(s) or the main endpoints in case of no formally defined primary endpoint(s).

Study explorer (study characteristics and results) method abbreviations pdf xlsx

COVID-19 mild to moderate meta-analysis

COVID 19 outpatients meta-analysis